4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-22-024228
Chief Scientific Officer acquired 28,084 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fisher Stewart Chief Scientific Officer | 2022-04-12 | Option exercise | +2,156 | $3.71 | $7,999 | 45,462 | D |
| Fisher Stewart Chief Scientific Officer | 2022-04-12 | Option exercise | +25,928 | $4.98 | $129,121 | 71,390 | D |
| Derivatives | |||||||
| Fisher Stewart Chief Scientific Officer | 2022-04-12 | Option exercise · Stock Option (Right to Buy) | −2,156 | 35,572 | D | ||
| Fisher Stewart Chief Scientific Officer | 2022-04-12 | Option exercise · Stock Option (Right to Buy) | −25,928 | 48,152 | D | ||
Loading xslF345X03/doc4.xml…